- Conditions
- Frailty, Inflammation
- Interventions
- Epigallocatechin-3-Gallate (EGCG) plus Ascorbic Acid (Vitamin C)
- Drug
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Rochester, New York
Source: ClinicalTrials.gov public record
Updated May 6, 2026 · Synced May 22, 2026, 1:30 AM EDT